Home > Healthcare > Biotechnology > Biotechnology Instruments Market

Biotechnology Instruments Market Share

Report ID: GMI7527
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Biotechnology Instruments Market Share

The biotechnology instruments industry is marked by intense competition, with key players focusing on innovation and strategic approaches. The market is dynamic, characterized by ongoing technological advancements with cutting-edge integrated solutions and a strong emphasis on R&D, driving the scientific progress to meet the healthcare needs.

Prominent market players operating in the biotechnology instruments industry is as mentioned below:

Thermo Fisher Scientific, Inc.
Abbott
Waters Corp.
Shimadzu Corp.
Agilent Technologies, Inc.
Bruker Corp.
PerkinElmer, Inc.
Zeiss Group
Bio-Rad Laboratories, Inc.
Illumina, Inc.
BIOMÉRIEUX S.A.
F. Hoffmann-La Roche AG
Sartorius AG
Avantor, Inc.
Eppendorf SE

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Biotechnology instruments industry size was USD 61.1 billion in 2022 and is expected to reach USD 96.1 billion by end of 2032 driven by the increasing demand for precision diagnostics, advances in molecular biologics and genomics along with the higher need for advanced analytical techniques.

Biotechnology analytical instruments market size is expected to record USD 38.5 billion by 2032 owing to pivotal role in enabling precise analysis and characterization of biological samples.

North America held 42% share of the global biotechnology instruments industry in 2022 due to the increasing focus on R&D initiatives coupled with increased public-private investments in the region

Some of the prominent biotechnology instrument providers are Thermo Fisher Scientific, Inc., Abbott, Waters Corp., Shimadzu Corp., Agilent Technologies, Inc., Bruker Corp., PerkinElmer, Inc., and Zeiss Group